Based on the analysis of Pfizer's profitability, liquidity, and operating efficiency, Pfizer Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Pfizer's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Net Debt is expected to grow to about 65.7 B, whereas Total Current Liabilities is forecasted to decline to about 21.5 B. Key indicators impacting Pfizer's financial strength include:
The essential information of the day-to-day investment outlook for Pfizer includes many different criteria found on its balance sheet. An individual investor should monitor Pfizer's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Pfizer.
Please note, the presentation of Pfizer's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pfizer's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pfizer's management manipulating its earnings.
Pfizer Stock Summary
Pfizer competes with Aquestive Therapeutics, Evoke Pharma, Ironwood Pharmaceuticals, Alkermes Plc, and ANI Pharmaceuticals. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people.
Foreign Associates
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Pfizer's current stock value. Our valuation model uses many indicators to compare Pfizer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pfizer competition to find correlations between indicators driving Pfizer's intrinsic value. More Info.
Pfizer Inc is regarded second in return on equity category among its peers. It is regarded third in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pfizer Inc is roughly 1.95 . At present, Pfizer's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pfizer by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Pfizer Inc Systematic Risk
Pfizer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pfizer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Pfizer Inc correlated with the market. If Beta is less than 0 Pfizer generally moves in the opposite direction as compared to the market. If Pfizer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pfizer Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pfizer is generally in the same direction as the market. If Beta > 1 Pfizer moves generally in the same direction as, but more than the movement of the benchmark.
Pfizer Thematic Clasifications
Pfizer Inc is part of several thematic ideas from Robots And Drones to Healthcare. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Pfizer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pfizer's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pfizer growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.0649
At present, Pfizer's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Pfizer March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pfizer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pfizer Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pfizer Inc based on widely used predictive technical indicators. In general, we focus on analyzing Pfizer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pfizer's daily price indicators and compare them against related drivers.
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.